The wrapup of the J-DAVID trial.
The J-DAVID Randomized Clinical Trial Visual Abstract
Aakash Shingada stepped up with a visual abstract for this week’s NephJC Chat.
Summary of the CAPTIVATE platform which will be a twitter spaces discussion
This week, we will discuss a registry trial: can a nationwide nudge fix a CKD treatment gap?
This week, we will discuss a pediatric nephrology trial: is tacrolimus superior to MMF in FRNS and SDNS?
This week, we will discuss a NEJM trial on uncontrolled hypertension: lorundrostat, an aldosterone synthase inhibitor, aims at the hormonal dark side driving resistance.
Aakash Shingada stepped up with a visual abstract for this week’s NephJC Chat.